Medical Products and Capabilities Enhancement Activities
Abstract
Guidance for Development of the Force-Medical Products and Capabilities Enhancement Activities: Funds will support developmental upgrades to medical systems, training systems, and products that have been fielded, are routinely used in a fixed facility, or that have been approved for full-rate production and for which procurement funding is anticipated in the current fiscal year or subsequent fiscal years. These funds will support testing and evaluation for the enhancement of fielded or procured medical systems/products and medically-related information technology systems, assessment of fielded medical products or medical practices in order to identify the need/opportunity for changes, and analyses of clinical intervention outcomes to enhance and improve indications for pharmaceutical products. Efforts address the Military Health System Concept of Operations documents and follow-on Capabilities Based Assessments/Joint Capability Documents, appropriate Component requirements, legislative and Executive directives, and others as appropriate. Coordination occurs through the planning and execution activities of the Defense Health Agency Component Acquisition Executive (DHA CAE).
Document Details
- Document Type
- R2 Budgetary Justification
- Publication Date
- Oct 01, 2022
- Source ID
- 0607100DHA_2_0130_PB_2022
- Change Summary Explanation
- N/A
- Service Agency Name
- Defense Health Agency
Entities
Organizations
- Defense Health Agency
Related Documents
- Child Project: GDF-Medical Products and Capabilities Enhancement Activities
- Child Accomplishment: 377A: GDF – Medical Products and Capabilities Enhancement Activities
- Child Project: AF Advanced Technology Development – Rapid Technology Transition
- Child Accomplishment: AF Advanced Technology Development – Rapid Technology Transition
- Child Project: CSI - Congressional Special Interests